Compare EFSI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EFSI | TKNO |
|---|---|---|
| Founded | 1881 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.9M | 268.1M |
| IPO Year | 1996 | 2021 |
| Metric | EFSI | TKNO |
|---|---|---|
| Price | $45.66 | $6.96 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $41.50 | N/A |
| AVG Volume (30 Days) | 39.1K | ★ 261.0K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 1.61 | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $31.93 | $8.27 |
| Revenue Next Year | $4.38 | $13.13 |
| P/E Ratio | $28.74 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $31.44 | $1.91 |
| 52 Week High | $46.95 | $7.84 |
| Indicator | EFSI | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 68.70 | 52.72 |
| Support Level | $38.81 | $4.87 |
| Resistance Level | N/A | $7.68 |
| Average True Range (ATR) | 1.38 | 0.39 |
| MACD | 0.35 | -0.11 |
| Stochastic Oscillator | 80.39 | 17.68 |
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.